bioinformatics data News
-
Profacgen Updated Its In Silico Protein-protein Interactions Prediction Service
Profacgen, a biotechnology company that offers bioinformatics platform to help academic and industrial researchers to explore, understand and analyze complex biological data in various biotechnological programs and projects, recently updated its in silico protein-protein interactions prediction service to meet diversified needs of its customers. As one of the most common molecules in cells, ...
By Profacgen
-
BioLizard and JADBio Announce Partnership
JADBio and BioLizard today announced their partnership. BioLizard is an agile bioinformatics and AI/ML company globally servicing clients in the life sciences, biotechnology and pharmaceutical industries. JADBio is a robust Automated Machine Learning platform that allows intuitive, timely, and interactive creation of ML predictive models on BioMedical and Multi-omics data, while allowing for ...
By JADBio
-
Profacgen Enables Custom Bioinformatics Software Development for Researchers Worldwide
Profacgen, a US-based biotechnology company, recognizing the importance of computational technologies for pursuing advanced research in modern biology, released custom bioinformatics software development to offer support for both academic and industrial researchers to explore, understand and analyze complex biological data in a variety of biotechnology programs and projects. Bioinformatics ...
By Profacgen
-
MedBiome licenses the MetaLab metaproteomic software
MedBiome is pleased to announce that it has licensed the iMetaLab software platform from the University of Ottawa. iMetaLab (imetalab.ca) is a leading bioinformatics software for metaproteomics data analysis. MedBiome uses the iMetaLab software in combination with the RapidAIM assay to identify Precision Microbiome Therapeutics that change the composition of the human microbiome, ...
-
SeqOne wins prestigious iLab grant to improve genomics analysis software in healthcare
SeqOne a French start-up in the genomic medicine market is proud to announce that it has been awarded an i-Lab grant by the Ministry of Education and Technology. i-Lab is a national competition open to all French start-ups designed to identify the most promising technical innovations by France’s most forward-thinking start-ups. The award is associated with a grant aimed at helping each ...
-
Accelerating Drug Development with CD ComputaBio's Advanced Drug Design and CADD Solutions
CD ComputaBio, a reputable computational service provider in the field of biology, is dedicated to supporting research and trials by offering access to the latest software, technologies, and expertise at competitive prices and with fast turnaround times for researchers. Recently, the company introduced a series of state-of-the-art services in Drug Design and Computer-Aided Drug Design (CADD) with ...
-
Abcuro announces $8m series a financing
Abcuro, a leading biotechnology company focused on immunology therapeutics, announced the completion of a $8M Series A financing round. Partners Innovation Fund, Kaitai Capital, and ShangPharma Innovation all contributed to the round. The proceeds from this financing will be used to advance the preclinical development of Abcuro’s programs in autoimmunity and immuno-oncology. Abcuro is ...
By Abcuro, Inc.
-
CD Genomics: The Biomedical Bioinformatics Platform Unveils Biomarker and Target Discovery Data Analysis Service
The Biomedical Bioinformatics Platform belongs to CD Genomics and has a good reputation for assisting researchers with data analysis challenges, including NGS data processing, analysis, interpretation, and general genomic data analysis, as well as data mining, statistical modeling, data integration, information science, database construction, and management. Recently, the company announced the ...
By CD Genomics
-
Creative Proteomics Upgraded Exosome Proteomics Service to Accelerate Biomarker Discovery Research
Creative Proteomics, an integrated CRO company committed to providing a full range of services to support various proteome-related research projects from identification of single proteins to large-scale proteomic studies, has recently upgraded its fully-developed Exosome Proteomics Service to identify and quantify the proteins in exosomes. The company can also help discover biomarkers after ...
-
CD Genomics Unveils Cutting-Edge CRISPR Screen Sequencing Technology
CD Genomics, a distinguished leader in genomics and sequencing services, has proudly unveiled its groundbreaking CRISPR Screen Sequencing technology. This innovative solution promises to expedite discoveries, facilitate target identification, and optimize drug development pipelines within the biotechnology and pharmaceutical industries. CRISPR Screen Sequencing, a genome-wide screening ...
By CD Genomics
-
Appointment boosts CSIRO bioinformatics research
“Bioinformatics, the interface between computing and biology, is a fast growing field and Dr Jermiin’s appointment is part of CSIRO’s move to build its skills base in genome bioinformatics,” CSIRO Entomology’s Chief, Dr Mark Lonsdale said. “Given Dr Jermiin’s experience and research excellence, we are excited about what he brings to our research in genome bioinformatics.” Dr Jermiin’s ...
-
Creative Proteomics Lipidomics Introduces Glycerophospholipids Analysis Service
Lipidomics, a platform developed by Creative Proteomics, is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomics services for biomedical research institutions, and biotechnological and pharmaceutical companies. Creative Proteomics launches rapid and cost-effective glycerophospholipids analysis based on a highly stable, repeatable, and highly sensitive system for separation, ...
-
Metatranscriptome Analysis Service Is Now Available at CD Genomics
The Bioinformatics-Analysis, a subdivision of CD Genomics, provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis services. CD Genomics provides metatranscriptome sequencing data analysis service using bioinformatics analysis platform, which can comprehensively ...
By CD Genomics
-
Epigenetics Data Analysis Service Now Available by CD Genomics’s Bioinformatics-Analysis Platform
Bioinformatics-analysis Platform belongs to CD Genomics, which provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis business. The platform is a leading open solution for data-driven innovation, which aims to discover the hidden potential in biological data and ...
By CD Genomics
-
SeqOne Genomics closes €20M series A to accelerate the deployment of its genomic medicine platform
The round, led by Omnes, Merieux Equity Partners, together with the Software Club and existing investors, Elaia and IRDI Capital Investissement, will enable SeqOne Genomics to accelerate its international sales and the development of new collaborative genomic analysis tools to facilitate communications between different disciplines in the medical team, in order to improve patient outcomes in ...
-
CENTOGENE and Molecular Health Announce an Exclusive Collaboration With the Aim to Transform the Development of Orphan Drugs
The combination of real-life data sets in rare diseases with innovative big data/artificial intelligence/novel scientific computational knowledge will transform biomedical research, product development, and therapy. Real-life data and Innovative Bioinformatic Algorithms (RIBA project) will enable the creation of a powerful environment to accelerate, de-risk, and improve the development of new ...
-
Agilent Technologies adds new integrated biology capabilities to bioinformatics suite
Agilent Technologies Inc. (NYSE: A) today released GeneSpring 12.0, a major expansion of its popular bioinformatics software designed to enable a new level of medical science breakthroughs. With the new release, GeneSpring users can now analyze next-generation sequencing data and conduct joint analysis at the pathway level across multiple "omics" platforms in a familiar software environment. ...
-
Creative Proteomics Lipidomics Launches Steroids Analysis Service
Lipidomics, a platform developed by Creative Proteomics, is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomics services for biomedical research institutions, and biotechnological and pharmaceutical companies. Creative Proteomics Lipidomics launched the steroid analysis service capable of quantifying up to 38 steroids in biological matrices such as plasma, serum, tissue, ...
-
Agilent Technologies expands next-generation sequencing target-enrichment platform with SureCall Software upgrade
Agilent Technologies Inc. (NYSE: A) today introduced SureCall version 2.0 software, expanding the capabilities of the company's current market-leading, next-generation sequencing target-enrichment solutions. The newly upgraded software features compatibility with SureSelect custom target-enrichment and Human All Exon panels. One of the biggest challenges faced by clinical research labs when ...
-
Creative Proteomics Launches Crotonylation Proteomics Analysis Service to Enhance Your Epigenetic Research
Creative Proteomics, a leading provider of proteomics, metabolomics, and bioinformatics services, is pleased to announce the launch of its new Crotonylation Proteomics Analysis Service. This service is designed to provide researchers with a comprehensive and in-depth analysis of crotonylation, a newly discovered post-translational modification (PTM) of lysine residues. Crotonylation, a recently ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you